Connection
Nicholas Foreman to G2 Phase Cell Cycle Checkpoints
This is a "connection" page, showing publications Nicholas Foreman has written about G2 Phase Cell Cycle Checkpoints.
|
|
Connection Strength |
|
 |
|
 |
|
0.050 |
|
|
|
-
Wang D, Veo B, Pierce A, Fosmire S, Madhavan K, Balakrishnan I, Donson A, Alimova I, Sullivan KD, Joshi M, Erlander M, Ridinger M, Foreman NK, Venkataraman S, Vibhakar R. A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy. Neuro Oncol. 2022 03 12; 24(3):414-426.
Score: 0.050